ZA913794B - 3-(1-thiazolidinylbutyl-4-piperazinyl)-1h-indazoles,a process for their preparation and their use as medicaments - Google Patents

3-(1-thiazolidinylbutyl-4-piperazinyl)-1h-indazoles,a process for their preparation and their use as medicaments

Info

Publication number
ZA913794B
ZA913794B ZA913794A ZA913794A ZA913794B ZA 913794 B ZA913794 B ZA 913794B ZA 913794 A ZA913794 A ZA 913794A ZA 913794 A ZA913794 A ZA 913794A ZA 913794 B ZA913794 B ZA 913794B
Authority
ZA
South Africa
Prior art keywords
loweralkyl
thiazolidinylbutyl
indazoles
piperazinyl
medicaments
Prior art date
Application number
ZA913794A
Other languages
English (en)
Inventor
Nicholas J Hrib
J Hrib Nicholas
John G Jurcak
G Jurcak John
Joseph T Strupczewski
T Strupczewski Joseph
Kenneth Bordeau
Bordeau Kenneth
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of ZA913794B publication Critical patent/ZA913794B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
ZA913794A 1990-05-21 1991-05-20 3-(1-thiazolidinylbutyl-4-piperazinyl)-1h-indazoles,a process for their preparation and their use as medicaments ZA913794B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/526,089 US5041445A (en) 1990-05-21 1990-05-21 3-[1-thiazolidinylbutyl-4-piperazinyl]-1H-indazoles

Publications (1)

Publication Number Publication Date
ZA913794B true ZA913794B (en) 1992-02-26

Family

ID=24095872

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA913794A ZA913794B (en) 1990-05-21 1991-05-20 3-(1-thiazolidinylbutyl-4-piperazinyl)-1h-indazoles,a process for their preparation and their use as medicaments

Country Status (23)

Country Link
US (1) US5041445A (es)
EP (1) EP0458234B1 (es)
JP (1) JP3161755B2 (es)
KR (1) KR100215616B1 (es)
AT (1) ATE178327T1 (es)
AU (1) AU642243B2 (es)
CA (1) CA2042982A1 (es)
CZ (1) CZ280005B6 (es)
DE (1) DE69131057T2 (es)
DK (1) DK0458234T3 (es)
ES (1) ES2130125T3 (es)
FI (1) FI94757C (es)
GR (1) GR3030233T3 (es)
HU (1) HU215845B (es)
IE (1) IE911708A1 (es)
IL (1) IL98184A (es)
MX (1) MX25858A (es)
NO (1) NO179749C (es)
NZ (1) NZ238184A (es)
PL (1) PL165731B1 (es)
PT (1) PT97720B (es)
RU (2) RU2038355C1 (es)
ZA (1) ZA913794B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3875073T2 (de) * 1987-11-20 1993-03-11 Hoechst Roussel Pharma 3-(4(1-substituierte-4-piperazinyl)butyl)-4-thiazolidinone, verfahren zu deren herstellung und ihre anwendung als arzneimittel.
US5801186A (en) 1987-11-20 1998-09-01 Hoechst Marion Roussel, Inc. 3- 4-(1-substituted-4-piperazinyl)butyl!-4-thiazolidinone and related compounds
CA2157348A1 (en) * 1994-09-01 1996-03-02 Aventis Pharmaceuticals Inc. 3-¬4-(1-substituted-4-piperazinyl)butyl|-4-thiazolidinone and related compounds
CA2637531A1 (en) * 2006-02-17 2007-08-30 Memory Pharmaceuticals Corporation Compounds having 5-ht6 receptor affinity
KR20100053626A (ko) * 2007-08-15 2010-05-20 메모리 파마슈티칼스 코포레이션 5-ｈｔ6 수용체 친화성을 나타내는 3'-치환된 화합물
US20100016297A1 (en) * 2008-06-24 2010-01-21 Memory Pharmaceuticals Corporation Alkyl-substituted 3' compounds having 5-ht6 receptor affinity
US20100029629A1 (en) * 2008-07-25 2010-02-04 Memory Pharmaceuticals Corporation Acyclic compounds having 5-ht6 receptor affinity
US20100056531A1 (en) * 2008-08-22 2010-03-04 Memory Pharmaceuticals Corporation Alkyl-substituted 3' compounds having 5-ht6 receptor affinity
JP5760300B2 (ja) 2009-09-10 2015-08-05 株式会社リコー インクジェット用インク組成物材料及びインクジェット用インク組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4100282A (en) * 1972-12-23 1978-07-11 Boehringer Ingelheim Gmbh N-Aryl-N'-(phenyl- or phenoxy-alkyl)-piperazines and salts thereof
DE3132916A1 (de) * 1981-08-20 1983-03-03 Kali-Chemie Pharma Gmbh, 3000 Hannover 1-phenylindazol-3-on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4775761A (en) * 1983-08-22 1988-10-04 Hoechst-Roussel Pharmaceuticals, Inc. 3-(piperidinyl)- and 3-(pyrrolidinyl)-1H-indazoles
EP0302423A3 (en) * 1987-08-07 1991-01-09 Hoechst-Roussel Pharmaceuticals Incorporated 1-phenyl-3-(1-piperazinyl)-1h-indazoles, a process and intermediates for their preparation, and the use thereof as medicaments
DE3875073T2 (de) * 1987-11-20 1993-03-11 Hoechst Roussel Pharma 3-(4(1-substituierte-4-piperazinyl)butyl)-4-thiazolidinone, verfahren zu deren herstellung und ihre anwendung als arzneimittel.
NZ230045A (en) * 1988-08-05 1990-11-27 Janssen Pharmaceutica Nv 3-piperazinylbenzazole derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
GR3030233T3 (en) 1999-08-31
EP0458234B1 (en) 1999-03-31
HU215845B (hu) 1999-04-28
FI912401A (fi) 1991-11-22
FI94757C (fi) 1995-10-25
HU911697D0 (en) 1991-11-28
PT97720A (pt) 1992-02-28
US5041445A (en) 1991-08-20
KR910020007A (ko) 1991-12-19
JP3161755B2 (ja) 2001-04-25
RU2038355C1 (ru) 1995-06-27
FI912401A0 (fi) 1991-05-17
NZ238184A (en) 1993-01-27
PL165731B1 (pl) 1995-02-28
IE911708A1 (en) 1991-12-04
MX25858A (es) 1993-09-01
CZ148091A3 (en) 1993-08-11
DE69131057D1 (de) 1999-05-06
NO179749B (no) 1996-09-02
NO179749C (no) 1996-12-11
IL98184A (en) 1995-03-15
JPH04226979A (ja) 1992-08-17
EP0458234A3 (en) 1992-09-30
DK0458234T3 (da) 1999-10-11
ES2130125T3 (es) 1999-07-01
NO911921D0 (no) 1991-05-16
KR100215616B1 (ko) 1999-08-16
HUT61018A (en) 1992-11-30
IL98184A0 (en) 1992-06-21
EP0458234A2 (en) 1991-11-27
AU7618191A (en) 1991-11-21
CZ280005B6 (cs) 1995-09-13
FI94757B (fi) 1995-07-14
RU2105765C1 (ru) 1998-02-27
DE69131057T2 (de) 1999-09-09
CA2042982A1 (en) 1991-11-22
ATE178327T1 (de) 1999-04-15
NO911921L (no) 1991-11-22
AU642243B2 (en) 1993-10-14
PT97720B (pt) 1998-09-30
PL290327A1 (en) 1992-05-04

Similar Documents

Publication Publication Date Title
ZA888651B (en) 3-(4(1-substituted-4-piperazinyl)butyl)-4-thiazolidinones,a process for their preparation and their use as medicaments
HU9301866D0 (en) Benzoxa-condensed-ring-compounds and medical preparatives containing these compounds and processes for production of these compounds and of pharmaceutical composition
IL129322A0 (en) Novel ethylamine derivatives
IL98184A0 (en) 3-(1-thiazololidinylbutyl-4-piperazinyl-1h-indazoles,a process for their preparation and their use as medicaments
IL94665A0 (en) N-heteroaryl-purin-6-amines,process for their preparation and their use as medicaments
RU93005087A (ru) 3-(тиазолидинилбутил-4-пиперазинил)-ih-индазолы
HU896638D0 (en) Process for the preparation of acyloxypropanolamines and pharmaceutical compositions thereof
GR3023381T3 (en) Process for preparing trans-piperidine-2,5-dicarboxylates
SE8901060D0 (sv) New compounds
IL99434A0 (en) 3-(1h-indazol-3-yl)-4-pyridinamines,a process and intermediates for their preparation and pharmaceutical compositions containing them